Leading global vaccine products by revenue 2022
Top vaccine products
Vaccines act as a preventive measure to improve immunity to certain diseases. Often, vaccines are created from a weakened or killed form of a microbe which allows the immune system to react and create a record of it, so that in the future, it can easily recognize these microorganisms. Vaccine use can easily help to prevent contraction of certain viruses such as influenza. However, some countries may not have easy access to vaccinations.
The global vaccination market generated around 41 billion U.S. dollars in 2021 and is projected to reach around 67 billion U.S. dollars in 2026. In 2022, Comirnaty and Gardasil were the top revenue generating vaccines in the world, generating 37.8 billion and 6.9 billion U.S. dollars, respectively. Comirnaty is marketed by Pfizer and BioNTech, while Gardasil is marketed by Merck & Co.